Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CTLA4 antibody

This Mouse Monoclonal antibody specifically detects CTLA4 in ELISA and in vivo. It exhibits reactivity toward Human.
Catalog No. ABIN7543361

Quick Overview for Recombinant CTLA4 antibody (ABIN7543361)

Target

See all CTLA4 Antibodies
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Antibody Type

Recombinant Antibody

Reactivity

  • 147
  • 77
  • 45
  • 14
  • 3
Human

Host

  • 85
  • 80
  • 17
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Mouse

Clonality

  • 117
  • 72
  • 3
Monoclonal

Conjugate

  • 104
  • 16
  • 13
  • 11
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CTLA4 antibody is un-conjugated

Application

  • 90
  • 90
  • 62
  • 57
  • 43
  • 36
  • 19
  • 13
  • 10
  • 7
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
ELISA, In vivo Studies (in vivo)

Clone

5E3
  • Purpose

    Anti-CTLA-4 [5E3], Mouse IgG1, kappa

    Specificity

    The antibody is specific for CTLA-4. CTLA-4 is a protein receptor that functions as an immune checkpoint and downregulates immune responses.

    Characteristics

    Original Species of Ab: Mouse

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogen

    The original antibody was generated by immunizing BALB/c mice with CTLA-4 protein.

    Isotype

    IgG1 kappa
  • Application Notes

    The specificity of the antibody was confirmed by ELISA analysis. The kinetic parameters of human CTLA-4 protein binding to the antibody were measured and they resulted to be at the sub-nm level. The antitumor activity of the humanized antibody was demonstrated in vivo in animal models. It was proved that the antibody inhibited the tumor in a dose-dependent manner. Mouse PD-1 antibody was combined with the antibody and used to evaluate the toxicity to mice, these experiments compared with the use of Ipilimumab in combination with PD-1 antibody. Results showed that after 5E3 antibody was used in combination with PD-1 antibody, the immunity to the body and the toxicity of heart, liver and lung are significantly lower than the toxicity of Ipilimumab in combination with PD-1 antibody (CN110343180).

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Alternative Name

    CTLA-4

    Background

    Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, CD152

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!